Here, we showed that the expression of RASSF5 is significantly increased in TET1-overexpressing cells, in comparison with that in the controls, and that the methylation levels of RASSF5 promoter region are increased in ovarian cancer cells, which agrees with the results obtained in the previous studies. Here, RASSF5 is linked to ovarian carcinoma.